Bio-Techne Acquires Advanced Cell Diagnostics in $325 Million Deal

Bio-Techne has closed its acquisition of Advanced Cell Diagnostics for $250 million in cash plus $75 million in contingent payments if milestones are hit. Both companies are headquartered in the US and supply laboratory tools. ACD was founded by prominent China-US scientists, Dr. Yuling Luo and Dr. Steve Chen. ACD has developed an RNA in situ hybridization technology that monitors gene expression at the cellular level, while maintaining important morphology information. More details.... Stock Symbol: (NSDQ: TECH) Share this with colleagues: // //